FCGR3B and non-small cell lung carcinoma: Neutrophils were identified by expression of the CD16b antigen19–21, which was validated in a fresh NSCLC sample by flow cytometry which demonstrated distinct CD16b+ neutrophil and CD68+ macrophage populations (Supplementary Fig. 1A).